Rafael
Moncada Durruti
Consultor Médico
Publicaciones en las que colabora con Rafael Moncada Durruti (12)
2024
-
Clinical Perspectives, Eligibility, and Success Criteria for Bariatric/Metabolic Surgery
Advances in experimental medicine and biology, Vol. 1460, pp. 677-695
-
FNDC4 reduces hepatocyte inflammatory cell death via AMPKα in metabolic dysfunction-associated steatotic liver disease
Clinical Nutrition, Vol. 43, Núm. 9, pp. 2221-2233
2023
-
Antagonic effect of ghrelin and LEAP-2 on hepatic stellate cell activation and liver fibrosis in obesity-associated nonalcoholic fatty liver disease
European journal of endocrinology, Vol. 188, Núm. 7, pp. 564-577
-
Uroguanylin prevents hepatic steatosis, mitochondrial dysfunction and fibrosis in obesity-associated NAFLD
Metabolism: Clinical and Experimental, Vol. 147
2020
-
Impact of Routine and Long-Term Follow-Up on Weight Loss after Bariatric Surgery
Obesity Surgery, Vol. 30, Núm. 11, pp. 4293-4299
2018
-
Clinical usefulness of abdominal bioimpedance (ViScan) in the determination of visceral fat and its application in the diagnosis and management of obesity and its comorbidities
Clinical Nutrition, Vol. 37, Núm. 2, pp. 580-589
2017
-
Eligibility and success criteria for bariatric/metabolic surgery
Advances in Experimental Medicine and Biology (Springer New York LLC), pp. 529-543
2016
-
Cardiovascular prevention in obese patients
Current Pharmaceutical Design, Vol. 22, Núm. 37, pp. 5687-5697
-
Does Preincisional Infiltration with Bupivacaine Reduce Postoperative Pain in Laparoscopic Bariatric Surgery?
Obesity Surgery, Vol. 26, Núm. 2, pp. 282-288
-
Increased interleukin-32 levels in obesity promote adipose tissue inflammation and extracellular matrix remodeling: Effect of weight loss
Diabetes, Vol. 65, Núm. 12, pp. 3636-3648
-
Metabolic Surgery Enters the T2DM Treatment Algorithm
Trends in Endocrinology and Metabolism
-
Tratamiento quirúrgico de la obesidad: pros y contras
Anales de la Real Academia Nacional de Farmacia, Vol. 82, Núm. 2, pp. 225-233